Swiss National Bank Rhythm Pharmaceuticals, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Swiss National Bank holds 89,300 shares of RYTM stock, worth $5.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

89,300

Previous 88,700 0.68%

Holding current value

$5.01 Million

Previous $3.64 Million 28.45%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$40.81 - $55.0 $24,486 - $33,000	600 Added 0.68%	89,300 $4.68 Million
Q2 2024 Aug 08, 2024	SELL	$35.41 - $44.37 $162,885 - $204,102	-4,600 Reduced 4.93%	88,700 $3.64 Million
Q1 2024 May 07, 2024	BUY	$39.12 - $52.44 $140,832 - $188,784	3,600 Added 4.01%	93,300 $4.04 Million
Q4 2023 Feb 06, 2024	SELL	$21.39 - $49.64 $218,178 - $506,328	-10,200 Reduced 10.21%	89,700 $4.12 Million
Q3 2023 Nov 08, 2023	BUY	$15.81 - $27.8 $17,391 - $30,580	1,100 Added 1.11%	99,900 $2.29 Million
Q2 2023 Aug 09, 2023	BUY	$16.32 - $21.15 $24,480 - $31,724	1,500 Added 1.54%	98,800 $1.63 Million
Q1 2023 May 10, 2023	SELL	$16.88 - $34.24 $10,128 - $20,544	-600 Reduced 0.61%	97,300 $1.74 Million
Q4 2022 Feb 08, 2023	BUY	$22.21 - $30.25 $184,343 - $251,075	8,300 Added 9.26%	97,900 $2.85 Million
Q3 2022 Nov 09, 2022	BUY	$4.3 - $30.85 $27,090 - $194,355	6,300 Added 7.56%	89,600 $2.2 Million
Q1 2022 May 09, 2022	BUY	$6.13 - $12.24 $34,328 - $68,544	5,600 Added 7.21%	83,300 $960,000
Q3 2021 Nov 08, 2021	BUY	$11.68 - $20.72 $19,856 - $35,224	1,700 Added 2.24%	77,700 $1.02 Million
Q2 2021 Aug 06, 2021	SELL	$18.52 - $22.55 $50,004 - $60,885	-2,700 Reduced 3.43%	76,000 $1.49 Million
Q1 2021 May 07, 2021	BUY	$20.25 - $39.49 $479,925 - $935,913	23,700 Added 43.09%	78,700 $1.67 Million
Q3 2020 Nov 09, 2020	BUY	$18.13 - $30.61 $18,130 - $30,610	1,000 Added 1.85%	55,000 $1.19 Million
Q2 2020 Aug 05, 2020	SELL	$14.41 - $25.35 $80,696 - $141,960	-5,600 Reduced 9.4%	54,000 $1.2 Million
Q1 2020 May 08, 2020	BUY	$13.16 - $22.9 $32,900 - $57,250	2,500 Added 4.38%	59,600 $907,000
Q4 2019 Feb 06, 2020	BUY	$19.53 - $25.5 $427,707 - $558,450	21,900 Added 62.22%	57,100 $1.31 Million
Q2 2019 Aug 02, 2019	BUY	$21.11 - $28.48 $82,329 - $111,072	3,900 Added 12.46%	35,200 $774,000
Q1 2019 May 10, 2019	BUY	$24.76 - $31.66 $27,236 - $34,826	1,100 Added 3.64%	31,300 $858,000
Q4 2018 Feb 13, 2019	BUY	$24.11 - $31.34 $38,576 - $50,144	1,600 Added 5.59%	30,200 $812,000
Q2 2018 Aug 09, 2018	BUY	$17.02 - $35.2 $486,772 - $1.01 Million	28,600 New	28,600 $894,000

Others Institutions Holding RYTM

# of Institutions

191

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Rhythm Pharmaceuticals, Inc. Transaction History